Investor Update

Basel, 16. September 2020

Invitation to Roche’s 3rd Quarter Sales 2020 Webinar

Roche will publish its Sales Results for the 3rd Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, October 15th, 2020.
 

07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)


Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here


14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT


The webinar will start with presentations by senior management, followed by a Q&A session.


Presenters:

  • Severin Schwan, CEO Roche Group
  • Bill Anderson, CEO Roche Pharmaceuticals
  • Thomas Schinecker, CEO Roche Diagnostics
  • Alan Hippe, Chief Financial and IT Officer


We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*


A replay of the webcast will be available via  ir.roche.com
 

*privacy notice

Best regards,
Karl Mahler
Head of Investor Relations
 
Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com
 
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
 
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
 
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com
Dr. Lisa Tuomi
Phone: +1 650 467 8737
e-mail: tuomi.lisa@gene.com